| Year |
Citation |
Score |
| 2020 |
Gundle KR, Deutsch GB, Goodman HJ, Pollack SM, Thompson MJ, Davis JL, Lee MY, Ramirez DC, Kerwin W, Bertout JA, Grenley MO, Sottero KHW, Beirne E, Frazier J, Dey J, et al. Multiplexed evaluation of microdosed antineoplastic agents in situ in the tumor microenvironment of patients with soft tissue sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32299817 DOI: 10.1158/1078-0432.Ccr-20-0614 |
0.487 |
|
| 2019 |
Deutsch GB, Pollack SM, Thompson MJ, Gundle KR, Bertout JA, Frazier JP, Beirne E, Grenley MO, Gong J, Liang Y, Beechem JM, Klinghoffer RA, Maki RG. Abstract 2155: High-plex spatial profiling analysis of multidrug CIVO microdose studies in cancer patients Cancer Research. 79: 2155-2155. DOI: 10.1158/1538-7445.Am2019-2155 |
0.469 |
|
| 2018 |
Klinghoffer R, Thompson MJ, Davidson DJ, Bertout JA, Sottero KHW, Grenley MO, Beirne E, Pollack S. Multidrug analyses in cancer patients via intratumoral microdosing with CIVO: A microinjection technology for phase 0 drug investigation. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E23569 |
0.461 |
|
| 2017 |
Frazier J, Bertout JA, Kerwin WS, Moreno-Gonzalez A, Casalini JR, Grenley MO, Beirne E, Watts KL, Keener A, Thirstrup DJ, Tretyak I, Ditzler S, Tripp CD, Choy K, Gillings S, et al. Multi-drug analyses in patients distinguish efficacious cancer agents based on both tumor cell killing and immunomodulation. Cancer Research. PMID 28364003 DOI: 10.1158/0008-5472.Can-17-0084 |
0.518 |
|
| 2015 |
Klinghoffer RA, Bahrami SB, Hatton BA, Frazier JP, Moreno-Gonzalez A, Strand AD, Kerwin WS, Casalini JR, Thirstrup DJ, You S, Morris SM, Watts KL, Veiseh M, Grenley MO, Tretyak I, ... ... Bertout JA, et al. A technology platform to assess multiple cancer agents simultaneously within a patient's tumor. Science Translational Medicine. 7: 284ra58. PMID 25904742 DOI: 10.1126/Scitranslmed.Aaa7489 |
0.498 |
|
| 2015 |
Frazier J, Moreno-Gonzalez A, Kerwin W, Bertout J, Casalini J, Watts K, Ditzler S, Deckwerth T, Klinghoffer RA. Toxicity-sparing in-tumor profiling of multiple drugs simultaneously in canine patients with sarcoma. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E22177 |
0.429 |
|
| 2015 |
Gonzalez AM, Frazier J, Kerwin W, Bertout J, Casalini J, Ditzler S, Caffo N, Klinghoffer RA. Abstract 2020: A platform to test multiple therapies simultaneously in the intact tumors of cancer patients: Initial clinical experience Cancer Research. 75: 2020-2020. DOI: 10.1158/1538-7445.Am2015-2020 |
0.505 |
|
| 2009 |
Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B, Brown EJ, Nathanson KL, Simon MC. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proceedings of the National Academy of Sciences of the United States of America. 106: 14391-6. PMID 19706526 DOI: 10.1073/Pnas.0907357106 |
0.399 |
|
| 2009 |
Bertout JA, Patel SA, Fryer BH, Durham AC, Covello KL, Olive KP, Goldschmidt MH, Simon MC. Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. Cancer Research. 69: 3213-20. PMID 19293180 DOI: 10.1158/0008-5472.Can-08-4223 |
0.383 |
|
| 2008 |
Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nature Reviews. Cancer. 8: 967-75. PMID 18987634 DOI: 10.1038/Nrc2540 |
0.323 |
|
| 2006 |
Bertout J, Thomas-Tikhonenko A. Infection & neoplastic growth 101: the required reading for microbial pathogens aspiring to cause cancer. Cancer Treatment and Research. 130: 167-97. PMID 16610708 |
0.325 |
|
| 2006 |
Bertout J, Thomas-Tikhonenko A. Infection & Neoplastic Growth 101 Cancer Treatment and Research. 130: 167-197. DOI: 10.1007/0-387-26283-0_8 |
0.361 |
|
| Show low-probability matches. |